Search Results 121-130 of 16677 for alopecia

  1. A Study to Evaluate Abemaciclib for Surgically Resectable, Chemotherapy-Resistant, Triple Negative Breast Cancer - Mayo Clinic

    Exceptions: Residual alopecia and Grade 2 peripheral neuropathy are allowed. Concurrent use of strong and moderate inducers and/or strong inhibitors of ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder, Telogen ...

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Alopecia areata, Melasma. Show more areas of focus for Ashley B. Wentworth, M.D.. Josh P. Wiedermann, M.D.. Otolaryngologist. Rochester ...

  4. Mayo Clinic Minute Treatment for hair loss and women Video Audio Vivien Williams What woman doesn’t want thick, luxurious

    What can you do about it? Well, Dr. Drage says that depends on why you're losing your hair. But, for the most common form of hair loss, over-the-.

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder, Telogen ...

  6. Hidradenitis suppurativa - Diagnosis and treatment - Mayo Clinic

    Uso de la espironolactona en dermatología: Acné, hidradenitis supurativa, alopecia femenina e hirsutismo. Actas Dermosifiliogr. 2020; doi: 10.1016/j.ad ...

  7. Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer - Mayo Clinic

    Patients should have resolution of any toxic effects of prior therapy (except alopecia) to National Cancer Institute (NCI) Common Terminology Criteria for ...

  8. Publications - Afsaneh Alavi, M.D. - Mayo Clinic

    Scarring hidradenitis suppurativa with phrynoderma-like eruption, alopecia, and elevated interleukin 18. JAAD Case Rep. 2025 Jan; 55:116-120 Epub 2024 Nov ...

  9. Preclinical modeling for radiation-induced hyposalivation - Mayo Clinic

    The mice tolerated radiation doses of 2.5 to 7.5 gray, but doses greater than 5 gray led to chronic alopecia in the mandibular region. While different study ...

  10. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

    - Subjects with vitiligo or alopecia - Subjects with hypothyroidism (eg, following Hashimoto's thyroiditis) stable on hormone replacement therapy or ...